A recent multi-site study published in Radiology was designed to gauge the difference in imaging quality for prostate MRI by looking retrospectively at performance across 26 institutions. They found that the positive predictive value of the test for prostate cancer was highly variable at different sites.
Read the full article here
The Healthy Youth Development - Prevention Research Center (HYD-PRC) attributes the rise in STI rates to a combination of factors, including barriers to prevention, screening and treatment services, education, transportation, cost, concerns about confidentiality and peer and media influences.
First randomized clinical trial of Hydroxychloroquine to prevent COVID-19 following exposure.
Marc Jenkins, PhD, director of the Center for Immunology and Regents' and Distinguished McKnight Professor in the Department of Microbiology and Immunology at the University of Minnesota Medical School, has been elected to the National Academy of Sciences (NAS). He is the first U of M Medical School faculty member to be elected to the NAS in 50 years.
University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19.
The University of Minnesota today is launching a clinical trial on a post-exposure treatment for coronavirus COVID-19 disease.
The team hopes it will accelerate biomedical research and offer a new protocol for studying the vulnerability of the model and a new cardiovascular phenotype.
The Medical School at the University of Minnesota recently recognized Dr. Marco Pravetoni, Associate Professor of Pharmacology, for his effort to combat the opioid epidemic with novel vaccines.
The U of M increases three spots in Blue Ridge Institute of Medical Research rankings.